The UK pharmaceutical sector has raised concerns that the government’s current stance on drug pricing is discouraging foreign investment and undermining the country’s competitiveness as a life sciences hub.
Industry groups argue that strict pricing controls and rebate requirements are limiting the returns companies can make on innovative treatments, pushing global drugmakers to prioritize other markets. The Association of the British Pharmaceutical Industry (ABPI) said the policy risks driving research and development spending away from the UK at a time when attracting investment is crucial.
Executives have urged the government to strike a better balance between affordability for the National Health Service and incentives for innovation. They warn that without changes, the UK could fall behind in securing new medicines and clinical trials, weakening its long-term position in the global pharmaceutical landscape.
This Article is published by Epic Click Travel & Tourism.
Epic Click Travel & Tourism is a professional travel agency based in Dubai.
Epic Click Travel & Tourism will handle everything for you from flights to hotels, including fast-track airport check-in, private car transfers, and visas.
To learn more about Epic Click Travel & Tourism, visit https://epicclicktravel.com.
You can also contact the company directly by email info@epicclicktravel.com and WhatsApp +971 52 427 5718
